Navigation Links
Health Outcome Liaisons Improve Decision Making for Pharmaceutical Industry Challenged by Reform and Compliance Issues
Date:8/31/2012

CHAPEL HILL, N.C., Aug. 31, 2012 /PRNewswire/ -- As healthcare outcomes data gains more influence with decision makers, Pharmaceutical and Medical Device executives are increasing their attention to the Health Outcomes Liaison (HOL) function.

A new Best Practices, LLC study found that HOLs are emerging as invaluable "information conduits" that have the potential to guide and refocus healthcare decision makers, delivering services that help payers and other groups determine which medicines, therapies, diagnostics and tests to support and reimburse.

The report, Health Outcomes Liaison Excellence: How the HOL Function Drives Value across the Healthcare Industry, explores how leading companies provide exceptional HOL services in an ever-changing business environment.  The research also examines best practices in HOL management and differentiation of HOLs from other positions that serve diverse customer groups such as physicians, patients, payers, and advocates.

Christopher Bogan, chief executive officer of Best Practices, LLC, and Daniel Pascheles, Ph.D., vice president at Merck & Co., Inc.,  underlined the growing value of health outcomes services in a jointly-authored an article, "The Ultimate Business Model: Planning that Thousand Year Future." The full text is published in the August 2012 issue of Pharmaceutical Executive, a leading trade journal for the pharmaceutical industry.

In their article, the authors suggest how HOLs can help biopharma reinvent itself in this struggling economy: "Health outcomes represent a large frontier of opportunities—all that may lead to greater insight regarding which therapies produce the most desirable and measurable results."

Likewise, the study found that although the HOL function is still in its infancy, it must be considered as an area of expansion, as its ultimate value and potential has yet to be realized. Given the expanding role of HOL groups and the challenging environment they face, it's critical for organizations to continually improve their HOL activities and services to ensure they are creating value for diverse customer groups. Some of the key topics covered by the research include:

  • Charting the scope, frequency, and timing of HOL services
  • Outlining methods HOLs use to engage internal and external customers and build lasting relationships
  • Identifying trends expected to impact the HOL function
  • HOL salaries, key responsibilities and competencies

To access the full report or to download a complimentary summary containing insights from this research, click on the following link: http://www3.best-in-class.com/rr1174.htm.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgen To Present At The Baird Healthcare Conference
2. Bacterin International to Present at Stifel Nicolaus 2012 Healthcare Conference on September 6, 2012
3. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
4. MGC Diagnostics Corporation Completes Sale of New Leaf Business Assets to Life Time - The Healthy Way of Life Company
5. Cyberonics To Present At Morgan Stanley 2012 Global Healthcare Conference
6. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
7. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
8. Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Healths TERC Gene Marker
9. Sams Club Offers Free Diabetes Health Screenings Event
10. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
11. Global RFID in Healthcare and Pharmaceuticals Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
(Date:7/12/2017)... 2017 CarpalAID is a revolutionary new product that relieves ... Carpal tunnel syndrome affects more than 8 million people a ... of men. The common methods of treating CTS are painful surgery, ... braces or gloves. ... CarpalAID is a clear patch worn on the palm ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today announced ... Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at the ... for the UVA Health System, brings 30 years of highly relevant experience to his ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch ... of - living - adjustment (COLA) is a bad deal for older and disabled ... price index (CPI) would grow even more slowly than the conventional one that is ...
Breaking Medicine News(10 mins):